Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Next-generation HBOCs in preclinical development at Hemosol

Feb. 14, 2000

Metabasis Therapeutics extends diabetes collaboration with Sankyo

Feb. 14, 2000

Miacalcin nasal spray receives Canadian approval as treatment for osteoporosis

Feb. 14, 2000

Generex initiates oral insulin trials in England

Feb. 14, 2000

IND filing in sight for new oral contraceptive

Feb. 14, 2000

Novartis bisphosphonate (Zometa) granted priority review status

Feb. 11, 2000

Lilly and Alkermes to develop pulmonary form of human growth hormone

Feb. 11, 2000

Nasal osteoporosis product enters U.S. clinical trials

Feb. 11, 2000

Chimeric contraceptive vaccines in development at Washington State University

Feb. 10, 2000

Insulin sensitizer-anorectic combinations disclosed by Takeda for NIDDM

Feb. 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...